Lessons in participant retention in the course of a randomized controlled clinical trial

被引：8

作者：

Idoko O.T. ^{[1
]}

Owolabi O.A. ^{[1
]}

Odutola A.A. ^{[1
]}

Ogundare O. ^{[2
]}

Worwui A. ^{[1
]}

Saidu Y. ^{[1
]}

Smith-Sanneh A. ^{[1
]}

Tunkara A. ^{[1
]}

Sey G. ^{[1
]}

Sanyang A. ^{[1
]}

Mendy P. ^{[1
]}

Ota M.O.C. ^{[3
]}

机构：

[1] Medical Research Council Unit, P. O Box 273, Banjul

[2] Ekiti State University Teaching Hospital, Ado Ekiti

[3] WHO Regional Office for Africa, Brazzaville

来源：

BMC Research Notes | / 7卷 / 1期

基金：

英国医学研究理事会;

关键词：

Mobile Phone; Trial Procedure; Randomize Control Clinical Trial; Immunization Service; Trial Team;

D O I：

10.1186/1756-0500-7-706

中图分类号：

学科分类号：

摘要：

Background: Clinical trials are increasingly being conducted as new products seek to enter the market. Deployment of such interventions is based on evidence obtained mainly from the gold standard of randomized controlled clinical trials (RCCT). A crucial factor in the ability of RCCTs to provide credible and generalisable data is sample size and retention of the required number of subjects at completion of the follow-up period. However, recruitment and retention in clinical trials are hindered by prevalent peculiar challenges in Africa that need to be circumvented. This article shares experiences from a phase II trial that recorded a high retention rate at 14 months follow-up at a new clinical trial site. Methods: Mothers bringing children less than two months of age to the health facility were given information and invited to have their child enrolled if the inclusion criteria were fulfilled. Participants were enrolled over 8 months. Trial procedures, duration and risks/benefits were painstakingly and sequentially explained to the communities, parents and relevant relatives before and during the trial period. The proportions of participants that completed or did not complete the trial were analyzed including the reasons for failure to complete all trial procedures. Results: 1044 individuals received information regarding the trial of which 371 returned for screening. 300 (81%) of them who fulfilled the inclusion criteria and did not meet any exclusion criteria were enrolled and 94% of these completed the trial. Consent withdrawal was the main reason for not completing the trial largely (75%) due to the father not being involved at the point of consenting or parents no longer being comfortable with blood sampling. Conclusions: Participant retention in clinical trials remains a crucial factor in ensuring generalisability of trial data. Appropriate measures to enhance retention should include continuous community involvement in the process, adequate explanation of trial procedures and risks/benefits; and innovative tracing of participants adapted for the setting. © 2014 Idoko et al.

引用

共 26 条

[1]

Davis L.L., Broome M.E., Cox R.P., Maximizing retention in community-based clinical trials, J Nurs Scholarsh, 34, pp. 47-53, (2002)

[2]

Mor M., Niv G., Niv Y., Patient retention in a clinical trial: A lesson from the rofecoxib (VIOXX) study, Dig Dis Sci, 51, pp. 1175-1178, (2006)

[3]

Ota M.O., Idoko O.T., Ogundare E.O., Afolabi M.O., Human immune responses to vaccines in the first year of life: Biological, socio-economic and ethical issues - A viewpoint, Vaccine, 31, pp. 2483-2488, (2013)

[4]

Morse E.V., Simon P.M., Besch C.L., Walker J., Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations, Appl Nurs Res, 8, pp. 8-14, (1995)

[5]

Hill P.D., Humenick S.S., Comparison of subjects who fully versus minimally participated in a breast-feeding study, West J Nurs Res, 17, pp. 328-334, (1995)

[6]

Senturia Y.D., McNiff Mortimer K., Baker D., Gergen P., Mitchell H., Joseph C., Wedner H.J., Successful techniques for retention of study participants in an inner-city population, Control Clin Trials, 19, pp. 544-554, (1998)

[7]

Moorman P.G., Newman B., Millikan R.C., Tse C.K., Sandler D.P., Participation rates in a case-control study: The impact of age, race, and race of interviewer, Ann Epidemiol, 9, pp. 188-195, (1999)

[8]

Moser D.K., Dracup K., Doering L.V., Factors differentiating dropouts from completers in a longitudinal, multicenter clinical trial, Nurs Res, 49, pp. 109-116, (2000)

[9]

Taylor K.M., Kelner M., Interpreting physician participation in randomized clinical trials: The physician orientation profile, J Health Soc Behav, 28, pp. 389-400, (1987)

[10]

Penn Z.J., Steer P.J., Reasons for declining participation in a prospective randomized trial to determine the optimum mode of delivery of the preterm breech, Control Clin Trials, 11, pp. 226-231, (1990)

← 1 2 3 →